Cognios Beta Neutral Large Cap Fund’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$410K Sell
2,072
-339
-14% -$62.1K 0.53% 79
2023
Q4
$415K Buy
2,411
+174
+8% +$26.7K 0.54% 85
2023
Q3
$331K Buy
+2,237
New +$404K 0.43% 94

Other funds holding RMD

Cognios Beta Neutral Large Cap Fund's RMD Position: Q1 2024 in Review

Cognios Beta Neutral Large Cap Fund reduced its ResMed (RMD) stake by 14% in Q1 2024, selling an estimated $62.1K and leaving 2,072 shares worth $410K. The position accounts for 0.53% of the portfolio, ranked #79.

Cognios Beta Neutral Large Cap Fund first reported a position in RMD in Q3 2023 and has held it in 3 quarters since. The position peaked at $415K in Q4 2023. 719 funds tracked by Wall St. Rank hold RMD as of Q1 2024.

  • Cognios Beta Neutral Large Cap Fund held 2,072 shares of ResMed worth $410K as of Q1 2024.
  • Cognios Beta Neutral Large Cap Fund sold 339 ResMed shares in Q1 2024, an estimated $62.1K.
  • ResMed made up 0.53% of Cognios Beta Neutral Large Cap Fund's portfolio in Q1 2024, its #79 holding.
  • Cognios Beta Neutral Large Cap Fund first reported a position in ResMed in Q3 2023 and has held it in 3 quarters since.
  • Cognios Beta Neutral Large Cap Fund's ResMed position peaked at $415K in Q4 2023.
  • 719 funds tracked by Wall St. Rank held ResMed as of Q1 2024.

Based on Cognios Beta Neutral Large Cap Fund's 13F filing for Q1 2024, filed 8 May 2024.